Alzheimer's drug gets extended test in small patient group
NCT ID NCT05522387
Summary
This study aimed to evaluate the long-term safety and potential effects of an experimental drug called XPro1595 in people with Alzheimer's disease. It was an extension study for 11 participants who had already completed a prior trial with the same drug. The goal was to see if weekly injections for up to 18 months were safe and if they could help slow cognitive decline or improve brain health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEMENTIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Austin Health
Ivanhoe, Victoria, 3079, Australia
-
Australian Alzheimer's Research Foundation
Perth, Western Australia, 6009, Australia
-
KaRa MINDS
Macquarie Park, New South Wales, 2113, Australia
-
Neuro Trials Victoria Pty Ltd T/A NeuroCentrix
Carlton, Victoria, 3053, Australia
Conditions
Explore the condition pages connected to this study.